Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Angiotensin-converting enzyme |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
thyroglobulinprotease |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Trypsinogen activation peptide |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Mast cell tryptase |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Serine protease |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Elastase |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Cathepsin |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Pepsin A |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Papain |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Subtilisin |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Trypsin (substance) |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Bromelin |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Pancreatic elastase |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Bromelains (substance) |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Factor I |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 66400 enheder/20000 enheder/75000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 3000 enheder/2400 enheder/3000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 65000 enheder/20000 enheder/65000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 8000 enheder/30000 enheder/30000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Protease-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 20000 enheder/4500 enheder/25000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 16600 enheder/5000 enheder/18750 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 30000 enheder/10000 enheder/30000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + pancreaslipase + pancreasprotease, kapsel à 65000 enheder/20000 enheder/65000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 40000 enheder/8000 enheder/45000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 33200 enheder/10000 enheder/37500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 12000 enheder/4000 enheder/12000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 39000 enheder/12000 enheder/39000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 6000 enheder/16000 enheder/6000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 664400 enheder/20000 enheder/75000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 56000 enheder/20000 enheder/44000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 58500 enheder/18000 enheder/58500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase 20000 enheder + lipase 5000 enheder + protease 20000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 25000 enheder/4000 enheder/25000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
amylase + lipase + protease 48000 enheder/16000 enheder/48000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Product containing human protease inhibitor protein (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Promelase |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Trypsin + trypsinogen |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Matrix metallopeptidase 2 |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Matrix metallopeptidase 9 |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Free pancreatic elastase |
Is a |
False |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase and endopeptidase and triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing amylase and endopeptidase and triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing amylase and endopeptidase and pancreatic lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase and endopeptidase and pancreatic lipase only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Product containing only amylase and endopeptidase and pancreatic lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
1 |
Chymotrypsin |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Pepsin B |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Pepsin C |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Chymotrypsin C |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Oryzin |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Pancreatic elastase II |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|
Polymorphonuclear neutrophil elastase |
Is a |
True |
Endopeptidase (substance) |
Inferred relationship |
Some |
|